SPIE BIOS | 23-28 JANUARY 2010
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XIX
Editor(s): David H. Kessel

9 Sessions, 28 Papers, 0 Presentations
Front Matter  (1)
Proceedings Volume 7551 is from: Logo
23-28 January 2010
San Francisco, California, United States
Front Matter
Proc. SPIE 7551, Front Matter for Volume 7551, 755101 (31 March 2010);
PDT Session 1
Proc. SPIE 7551, Effects of PDT on the endocytic pathway, 755102 (3 March 2010);
Proc. SPIE 7551, Molecular factors in cell (and tumor) response to photodynamic therapy: the role of Bid, 755103 (3 March 2010);
Proc. SPIE 7551, Theranostic nanocells for simultaneous imaging and photodynamic therapy of pancreatic cancer, 755104 (3 March 2010);
PDT Session 2
Proc. SPIE 7551, Vitamin D as a potential enhancer of aminolevulinate-based photodynamic therapy for nonmelanoma skin cancer, 755105 (3 March 2010);
Proc. SPIE 7551, In vivo detection of time-resolved singlet oxygen luminescence under PDT relevant conditions, 755106 (3 March 2010);
Proc. SPIE 7551, Spectroscopic evaluation of photodynamic therapy of the intraperitoneal cavity, 755109 (3 March 2010);
PDT Session 3
Proc. SPIE 7551, A fast heterogeneous algorithm for light fluence rate for prostate photodynamic therapy, 75510B (3 March 2010);
Proc. SPIE 7551, A treatment planning system for pleural PDT, 75510C (3 March 2010);
Proc. SPIE 7551, A heterogeneous optimization algorithm for reacted singlet oxygen for interstitial PDT, 75510E (3 March 2010);
Proc. SPIE 7551, In vivo PDT dosimetry: singlet oxygen emission and photosensitizer fluorescence, 75510F (5 March 2010);
PDT Session 4
Proc. SPIE 7551, Targeting cytochrome C oxidase in mitochondria with Pt(II)-porphyrins for photodynamic therapy, 75510G (3 March 2010);
Proc. SPIE 7551, Three-dimensional ovarian cancer models: imaging and therapeutic combinations, 75510I (3 March 2010);
Proc. SPIE 7551, Visualizing photodynamic therapy response with time-lapse OCT in an in vitro model of metastatic ovarian cancer, 75510J (5 March 2010);
PDT Session 5
Proc. SPIE 7551, Photodynamic therapy for locally advanced pancreatic cancer: early clinical results, 75510L (8 March 2010);
PDT Session 6
Proc. SPIE 7551, Preliminary study of optical properties of hematoporphyrin monomethyl ether (HMME), a new PDT sensitizer, 75510P (3 March 2010);
Proc. SPIE 7551, EGF targeted fluorescence molecular tomography as a predictor of PDT outcomes in pancreas cancer models, 75510Q (3 March 2010);
Proc. SPIE 7551, Novel visible light activated type 1 photosensitizers, 75510R (3 March 2010);
PDT Session 7
Proc. SPIE 7551, In vitro biological effects of novel type I photosensitizers and their mechanism of action, 75510S (3 March 2010);
Proc. SPIE 7551, Noninvasive assessment of tissue distribution and tumor pharmacokinetics of Pc 181, a silicon phthalocyanine analogue, in mice, 75510T (3 March 2010);
Proc. SPIE 7551, In vivo photodynamic inactivation of Psuedomonas aeruginosa in burned skin in rats, 75510V (5 March 2010);
Proc. SPIE 7551, Patient specific integrating spheres for the improvement of dosimetry in skin PDT, 75510W (3 March 2010);
Poster Session
Proc. SPIE 7551, Pre-clinic study of uniformity of light blanket for intraoperative photodynamic therapy, 755112 (3 March 2010);
Proc. SPIE 7551, Dependence of light fluence on treated depth with photosensitization reaction shortly after photosensitizer injection in rabbit myocardial tissue in vivo, 755114 (5 March 2010);
Proc. SPIE 7551, In vivo light dosimetry for HPPH-mediated pleural PDT, 755115 (5 March 2010);
Proc. SPIE 7551, In vivo sampling of Verteporfin uptake in pancreas cancer xenograft models: comparison of surface, oral, and interstitial measurements, 755116 (5 March 2010);
Proc. SPIE 7551, Analytic modeling of antibody versus nanocell delivery of photosensitizer, 755117 (3 March 2010);
Proc. SPIE 7551, Topical chlorophyll-pheophytin derivative-mediated photodynamic therapy for DMBA-induced hamster buccal pouch premaligant lesions: an in vivo study, 755118 (5 March 2010);
Back to Top